Proqr Therapeutics Bv Stock Price on May 19, 2023
| PRQR Stock | USD 3.67 0.23 6.69% |
Below is the normalized historical share price chart for ProQR Therapeutics BV extending back to September 18, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of ProQR Therapeutics stands at 3.67, as last reported on the 30th of November, with the highest price reaching 3.73 and the lowest price hitting 3.41 during the day.
If you're considering investing in ProQR Stock, it is important to understand the factors that can impact its price. ProQR Therapeutics is extremely dangerous given 3 months investment horizon. ProQR Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.11, which implies the firm had a 0.11% return per unit of risk over the last 3 months. We were able to break down and collect data for thirty different technical indicators, which can help you to evaluate if expected returns of 1.76% are justified by taking the suggested risk. Use ProQR Therapeutics Coefficient Of Variation of 953.19, semi deviation of 2.33, and Risk Adjusted Performance of 0.0897 to evaluate company specific risk that cannot be diversified away.
At this time, ProQR Therapeutics' Total Stockholder Equity is relatively stable compared to the past year. As of 11/30/2024, Common Stock is likely to grow to about 4.1 M, while Common Stock Shares Outstanding is likely to drop slightly above 41.6 M. . At this time, ProQR Therapeutics' Price Book Value Ratio is relatively stable compared to the past year. As of 11/30/2024, Price Earnings To Growth Ratio is likely to grow to 0.09, while Price Earnings Ratio is likely to drop (5.42). ProQR Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 18th of September 2014 | 200 Day MA 2.2244 | 50 Day MA 2.9986 | Beta 0.253 |
ProQR |
Sharpe Ratio = 0.1115
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | PRQR | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 15.83 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.76 actual daily | 35 65% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average ProQR Therapeutics is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ProQR Therapeutics by adding it to a well-diversified portfolio.
Price Book 15.413 | Enterprise Value Ebitda (2.10) | Price Sales 22.1192 | Shares Float 62.8 M | Wall Street Target Price 7.4 |
Related Headline
Alnylam Pharmaceuticals Headline on 19th of May 2023
Exercise or conversion by Akshay Vaishnaw of 30913 shares of... by Akshay Vaishnaw
Filed transaction by Alnylam Pharmaceuticals I officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
ProQR Therapeutics Valuation on May 19, 2023
It is possible to determine the worth of ProQR Therapeutics on a given historical date. On May 19, 2023 ProQR was worth 1.75 at the beginning of the trading date compared to the closed value of 1.88. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of ProQR Therapeutics stock. Still, in general, we apply an absolute valuation method to find ProQR Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of ProQR Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against ProQR Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 1.73 | 1.78 | 1.72 | 1.74 | 292,049 | |
05/19/2023 | 1.75 | 1.88 | 1.74 | 1.88 | 311,911 |
| 1.95 | 1.95 | 1.87 | 1.91 | 287,622 |
| Backtest ProQR Therapeutics | | | ProQR Therapeutics History | | | ProQR Therapeutics Valuation | Previous | Next |
ProQR Therapeutics Trading Date Momentum on May 19, 2023
| On May 22 2023 ProQR Therapeutics BV was traded for 1.91 at the closing time. The top price for the day was 1.95 and the lowest listed price was 1.87 . The trading volume for the day was 287.6 K. The trading history from May 22, 2023 was a factor to the next trading day price gain. The trading delta at closing time against the next closing price was 1.60% . The trading delta at closing time against the current closing price is 9.04% . |
ProQR Therapeutics Fundamentals Correlations and Trends
By evaluating ProQR Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among ProQR Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. ProQR financial account trend analysis is a perfect complement when working with valuation or volatility modules.About ProQR Therapeutics Stock history
ProQR Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ProQR is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ProQR Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ProQR Therapeutics stock prices may prove useful in developing a viable investing in ProQR Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 81 M | 41.6 M | |
| Net Loss | -58.6 M | -61.5 M |
ProQR Therapeutics Quarterly Net Working Capital |
|
ProQR Therapeutics Stock Technical Analysis
ProQR Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
ProQR Therapeutics Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
ProQR Therapeutics BV cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
ProQR Therapeutics November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how ProQR Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ProQR Therapeutics shares will generate the highest return on investment. By undertsting and applying ProQR Therapeutics stock market strength indicators, traders can identify ProQR Therapeutics BV entry and exit signals to maximize returns
ProQR Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for ProQR Therapeutics' price direction in advance. Along with the technical and fundamental analysis of ProQR Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of ProQR to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0897 | |||
| Jensen Alpha | 1.58 | |||
| Total Risk Alpha | (0.97) | |||
| Sortino Ratio | 0.4659 | |||
| Treynor Ratio | 5.25 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for ProQR Stock Analysis
When running ProQR Therapeutics' price analysis, check to measure ProQR Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ProQR Therapeutics is operating at the current time. Most of ProQR Therapeutics' value examination focuses on studying past and present price action to predict the probability of ProQR Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ProQR Therapeutics' price. Additionally, you may evaluate how the addition of ProQR Therapeutics to your portfolios can decrease your overall portfolio volatility.